Dihydropyrimidine dehydrogenase activity in a Korean population

Citation
Dr. Sohn et al., Dihydropyrimidine dehydrogenase activity in a Korean population, THER DRUG M, 21(2), 1999, pp. 152-154
Citations number
20
Categorie Soggetti
Pharmacology,"Pharmacology & Toxicology
Journal title
THERAPEUTIC DRUG MONITORING
ISSN journal
01634356 → ACNP
Volume
21
Issue
2
Year of publication
1999
Pages
152 - 154
Database
ISI
SICI code
0163-4356(199904)21:2<152:DDAIAK>2.0.ZU;2-I
Abstract
Dihydropyrimidine dehydrogenase (DPD) is the major metabolic enzyme in the catabolism of 5-fluorouracil, and the activity in normal tissues shows a wi de variation among individuals. Recent studies demonstrate the relevance of DPD in the pharmacokinetics, toxicity, and antitumor efficacy of 5-fluorou racil. We investigated the DPD activity in peripheral blood mononuclear cel l form 114 healthy subjects in Korea. The DPD activities in healthy volunte ers were shown to follow a unimodal distribution. The mean of the activity was 0.28 +/- 0.16 nmol/min/mg protein. A wide (13-fold) intersubject variab ility was observed (range, 0.06-0.80 nmol/min/mg protein), and, on average, DPD activity in women (0.26 +/- 0.14) was 13% lower than in men (0.30 +/- 0.16). These findings indicate that the activity of DPD in this study was h igher than in reports of research with French and white American population s.